Showing results (71-80 of 219) with videos related to
Sort By:
Pageof 22
Blood|July 1, 1991
Regulation of jun-B expression by a cyclic AMP (cAMP)-dependent mechanism in human myeloid cellsR Datta, T Nakamura, M L Sherman, et al.Oncogene|January 23, 1999
Determination of cell fate by c-Abl activation in the response to DNA damageS Kharbanda, Z M Yuan, R Weichselbaum, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 1994
Radiation induction of immediate early genes: effectors of the radiation-stress responseR R Weichselbaum, D Hallahan, Z Fuks, et al.Cancer Research|February 15, 1992
cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathwayE Rubin, S Kharbanda, H Gunji, et al.Cancer Research|May 8, 1999
In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX geneY T Tai, T Strobel, D Kufe, et al.Cell and Tissue Kinetics|November 1, 1983
Generation time of leukaemic blast progenitor cellsM Minden, P Major, J Griffin, et al.Molecular Pharmacology|July 1, 1994
1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cellsS Kharbanda, Y Emoto, H Kisaki, et al.European Journal of Clinical Investigation|September 27, 2003
Immature dendritic cell/tumor cell fusions induce potent antitumour immunityA Takeda, S Homma, T Okamoto, et al.Journal of Gastroenterology|January 5, 2002
Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in miceS Homma, G Toda, J Gong, et al.Molecular Cancer Therapeutics|December 7, 2002
The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen speciesL Yin, T Ohno, R Weichselbaum, et al.Pageof 22